| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tRNA-Gly (anticodon TCC) 1-1 | 1.000 | 0.077 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2012 | 2019 | |||||||||
|
helicase with zinc finger | 1.000 | 0.077 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2018 | ||||||||
|
rippling muscle disease 1 | 1.000 | 0.115 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1998 | 1998 | |||||||||
|
TGFB1-induced anti-apoptotic factor 1 | 1.000 | 0.077 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2019 | |||||||||
|
immunoglobulin superfamily DCC subclass member 4 | 1.000 | 0.077 | 2.4E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
glycerophosphodiester phosphodiesterase domain containing 3 | 1.000 | 0.077 | 1.7E-15 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
EPB41L4A antisense RNA 1 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2019 | |||||||||
|
X-ray radiation resistance associated 1 | 1.000 | 0.077 | 8.4E-09 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2017 | ||||||||
|
long intergenic non-protein coding RNA 337 | 1.000 | 0.077 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | |||||||||
|
cell division cycle 20B | 1.000 | 0.038 | 5.1E-12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
TUSC2 pseudogene 1 | 1.000 | 0.077 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | |||||||||
|
TPTE pseudogene 1 | 1.000 | 0.077 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2019 | |||||||||
|
SAMD12 antisense RNA 1 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | |||||||||
|
chronic lymphocytic leukemia up-regulated 1 | 1.000 | 0.115 | 1.7E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2012 | ||||||||
|
small nucleolar RNA, C/D box 104 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2018 | |||||||||
|
Hyperparathyroidism 3 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2001 | |||||||||
|
microRNA 3140 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | |||||||||
|
microRNA 1587 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
cAMP responsive element binding protein like 2 | 1.000 | 0.077 | 0.72 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
F-cell production 1 | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
guanylate binding protein 3 | 1.000 | 0.038 | 1.0E-18 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 1.000 | 0.038 | 4.9E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
prohibitin pseudogene 1 | 1.000 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
small nuclear ribonucleoprotein polypeptide A' | 1.000 | 0.077 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
signal sequence receptor subunit 3 | 1.000 | 0.077 | 0.75 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |